NDC 80705-100
ELEPSIA XR 1000 MG
Levetiracetam
ELEPSIA XR 1000 MG is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Tripoint Therapeutics, Llc. The primary component is Levetiracetam.
Product ID | 80705-100_11662182-a84d-455b-a4ee-5a97cd532b48 |
NDC | 80705-100 |
Product Type | Human Prescription Drug |
Proprietary Name | ELEPSIA XR 1000 MG |
Generic Name | Levetiracetam |
Dosage Form | Tablet, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2021-02-12 |
Marketing Category | NDA / |
Application Number | NDA204417 |
Labeler Name | TRIPOINT THERAPEUTICS, LLC |
Substance Name | LEVETIRACETAM |
Active Ingredient Strength | 1000 mg/1 |
Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |